Peter Siesjö, MD, PhD
Skane University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter Siesjö, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:38 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07364786 · Effect of Salovum® on Pressure, Oxygen and Inflammation in GlioblastomaPeter Siesjö · recruiting · Glioblastoma · principal investigator
- Ph2NCT05525273 · Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary CraniopharyngiomaEva Marie Erfurth, MD, PhD · recruiting · Craniopharyngioma
- Ph2NCT04117672 · Antisecretory Factor In Severe Traumatic Brain InjuryPeter Siesjö · recruiting · Traumatic Brain Injury · principal investigator
- Ph1/Ph2NCT04116138 · Antisecretory Factor in Primary Glioblastoma 1Peter Siesjö · completed · Glioblastoma, Cerebral Edema, Chemotherapy Effect · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.